1h Free Analyst Time
Disruptor Profile: Pear Therapeutics, Inc.Speak directly to the analyst to clarify any post sales queries you may have.
Summary
The report provides information and insights into Pear Therapeutics, Inc.'s, including -
- Overview of the company and its product offering
- Detailed insight into its business model, company type and headquarter
- Information on partnership and funding
- Biography of top management.
Scope
- Pear Therapeutics Inc. (Pear) is a pioneer in software-based prescription digital therapeutics (PDT) for the treatment of severe diseases and serious medical conditions.
Reasons to buy
- Gain insights into Pears's business operations.
- Gain insights into funding and partnerships
- Gain understanding about its technology focus.
Table of Contents
Company OverviewTechnology Focus
Product Overview
Partnerships & Funding
Key Employees
Appendix
Companies Mentioned
A selection of companies mentioned in this report includes:
- Sandoz
- Novartis
- EDBI Pte Ltd
- Blue Water Life Science Fund LP
- Bridge Builders Collaborative
- 5AM Venture Management LLC
- Novartis AG
- TrustBridge Partners
- Arboretum Ventures LLC
- Temasek Holdings (Private) Ltd
- JAZZ Venture Partners L.P.
